Recent Press Releases

20 Years ProBioGen: Invests €20 Million in Mammalian Manufacturing Expansion

20 Years ProBioGen: Invests €20 Million in Mammalian Manufacturing Expansion Berlin, Germany, September 9, 2014 / B3C newswire / - On the occasion of its 20th anniversary, ProBioGen AG announced...

Almac Forms Academia-Industry Collaboration to Develop Green Chemicals

Almac Forms Academia-Industry Collaboration to Develop Green Chemicals 8 September 2014--Almac, the contract development and manufacturing organisation, today announces its high level involvement in...

Theratechnologies Resumes Distribution of EGRIFTA (Tesamorelin for Injection) in the United States

Theratechnologies Resumes Distribution of EGRIFTA (Tesamorelin for Injection) in the United States MONTREAL, QUEBEC--(Marketwired - Sept. 3, 2014) - Theratechnologies Inc. (TSX:TH) is pleased to...

International Law Enforcement Action Against Fake Medicines

International Law Enforcement Action Against Fake Medicines The Hague, The Netherlands 1 September 2014 Law enforcement authorities from Austria, Belgium, Cyprus, France, Hungary, Slovakia, Spain and...

CPhI Worldwide to host #CPhIChat provoking debate on the future of pharma

CPhI Worldwide to host #CPhIChat provoking debate on the future of pharma Industry professionals and media are invited to participate in the inaugural Tweetchat taking place in real-time at CPhI...

NAFTA Tribunal Decision Supports FDA and Its Actions

NAFTA Tribunal Decision Supports FDA and Its Actions Toronto, ON – Apotex Inc., the largest Canadian owned pharmaceutical company, announced today that an arbitration tribunal rejected...

Novo Nordisk buys production plant in New Hampshire

Novo Nordisk buys production plant in New Hampshire Bagsværd, Denmark, 27 August 2014 - Novo Nordisk today announced the acquisition of a manufacturing facility in West Lebanon, New Hampshire,...

Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide

Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide - Merck Serono is the first and only multinational company in China to...

DPx Holdings B.V. Reaches Definitive Agreement to Acquire Gallus BioPharmaceuticals

DPx Holdings B.V. Reaches Definitive Agreement to Acquire Gallus BioPharmaceuticals Durham, N.C. and St. Louis — (August 27, 2014)—DPx Holdings B.V., privately owned by JLL Partners and...

Recipharm forms new collaboration with Isofol Medical to exclusively manufacture Modufolin® and invests SEK 8 million in the company

Recipharm forms new collaboration with Isofol Medical to exclusively manufacture Modufolin® and invests SEK 8 million in the company Recipharm and Isofol Medical AB, a Gothenburg-based...

PSC Investments Announces Acquisition of a High Potency, Sterile Fill Finish Pharmaceutical Manufacturing Facility From Morgridge Institute

PSC Investments Announces Acquisition of a High Potency, Sterile Fill Finish Pharmaceutical Manufacturing Facility From Morgridge Institute MADISON, Wis.--(BUSINESS WIRE)--PSC Investments, a...

Ampio reports that due to temperature deviations below product specifications during shipments to the Ampion™ STEP Study clinical sites, release of data will be delayed

Ampio reports that due to temperature deviations below product specifications during shipments to the Ampion™ STEP Study clinical sites, release of data will be delayed ENGLEWOOD, Colo., Aug....

Hikma delivers excellent first half results with 16% revenue growth and 44% increase in adjusted EPS

Hikma delivers excellent first half results with 16% revenue growth and 44% increase in adjusted EPS London, 20 August 2014 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC:...

FUJIFILM Diosynth Biotechnologies Expands Cell Culture Manufacturing Capacity with Addition of Two New 2,000L Single-Use Bioreactors

FUJIFILM Diosynth Biotechnologies Expands Cell Culture Manufacturing Capacity with Addition of Two New 2,000L Single-Use Bioreactors Billingham, Teesside, UK and Research Triangle Park, NC, USA,...

First antimalarial treatments produced with semisynthetic artemisinin enter market

First antimalarial treatments produced with semisynthetic artemisinin enter market First shipment marks a critical step in improving access to treatment worldwide Paris, France, and South San...

Ashland commits to major capacity expansion for Klucel™ products

Ashland commits to major capacity expansion for Klucel™ products Expansion aimed at meeting growing customer demand August 7, 2014 WILMINGTON, Del. - Ashland Specialty Ingredients, a...

Terumo BCT Announces Collaboration to Evaluate Clinical Cell Production Using Quantum System

Terumo BCT Announces Collaboration to Evaluate Clinical Cell Production Using Quantum System Project to evaluate system's capability and scalability in manufacturing allogeneic cell therapies for...

Baxter Opens its First State-of-the-Art Biologics Facility in Asia, Announces Expansion Plans with New Processing Suite

Baxter Opens its First State-of-the-Art Biologics Facility in Asia, Announces Expansion Plans with New Processing Suite Singapore-Based Facility Enhances Baxter's Global Capabilities to Support...

Alvogen Acquires Korean Dream Pharma for US$ 187 Million

Transaction creates one of South Korea's largest generic pharmaceuticals companies Significant step towards Alvogen's ambition to be a top-5 business in Asia Pacific Region (APAC) Third...

Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter

Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter Company Release -...